Comerica Bank’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Comerica Bank’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-54,807	Closed	-$611K	–	2313
2017 Q3	$611K	Buy	54,807 +820	+2%	+$9.04K	﹤0.01%	1827
2017 Q2	$591K	Sell	53,987 -2,762	-5%	-$27.6K	﹤0.01%	1785
2017 Q1	$565K	Buy	56,749 +2,585	+5%	+$25.8K	﹤0.01%	1839
2016 Q4	$571K	Buy	54,164 +3,531	+7%	+$35.3K	﹤0.01%	1822
2016 Q3	$521K	Buy	50,633 +761	+2%	+$8.29K	﹤0.01%	1767
2016 Q2	$532K	Buy	+49,872	New	+$653K	﹤0.01%	1759

Comerica Bank's SCLN Position: Q4 2017 in Review

Comerica Bank sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 54,807 shares — an estimated $611K sold.

Comerica Bank first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $611K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Comerica Bank reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Comerica Bank sold 54,807 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $611K.
Comerica Bank first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
Comerica Bank's Sciclone Pharmaceuticals Inc position peaked at $611K in Q3 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Comerica Bank's 13F filing for Q4 2017, filed 2 Feb 2018.